MedPath

Multimodal Analgesia for the Reduction of Postoperative Opioid Consumption

Early Phase 1
Withdrawn
Conditions
Pain
Interventions
Drug: Multimodal analgesia
Registration Number
NCT03817034
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The investigators are performing this research study to investigate the efficacy of local infiltration of the surgical wound combining dexmedetomidine, ropivacaine, and ketorolac (treatment group) versus the current standard of care (historical control group), for post-operative pain management.

Detailed Description

During this research study, patients recommended for a rectus sheath block during surgery will receive a novel combination of non-opioid drugs. Data from the treatment group will be compared to surgical outcomes of a historically matched control group to investigate the ability of this drug combination to reduce post-operative pain and post-operative opioid consumption.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Age greater than 18 years
  • American Society of Anesthesiologist Physical Status Classification 1-3
  • Undergoing surgery requiring a rectus sheath block
Exclusion Criteria
  • American Society of Anesthesiologist Physical Status Classification of 4 or beyond
  • history of opiate of illicit substance abuse, chronic pain, or neurological dysfunction

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Multimodal AnalgesiaMultimodal analgesia-
Primary Outcome Measures
NameTimeMethod
Change in post-operative opioid consumption48 hours

Decreased post-operative opioid consumption associated with use of multimodal analgesia

Change in post-operative pain scores48 hours

Decreased post-operative pain scores associated with use of multimodal analgesia

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath